Baxter International Stock Outlook: Is Wall Street Bullish or Bearish?

Deerfield, Illinois-based Baxter International Inc. (BAX) provides a broad portfolio of essential healthcare products used in hospitals, clinics, and patient homes. Valued at a market cap of $8.9 billion, the company continues to leverage its massive global footprint and "Fab-Right" localized manufacturing strategy to drive digital health innovation, specifically through AI-driven predictive monitoring and autonomous infusion technologies. 

This healthcare company has notably underperformed the broader market over the past 52 weeks. Shares of BAX have declined 45.9% over this time frame, while the broader S&P 500 Index ($SPX) has gained 29%. Moreover, on a YTD basis, the stock is down 13%, compared to SPX’s 5.6% rise.